From Sanctuary to Science Lab: Industry Leaders Lay Out Thailand's Wellness Roadmap

 

 

Senior executives from Chiva-Som and BDMS say Thailand must reframe wellness as a longevity investment — and back every claim with laboratory proof.

 

 

Three of Thailand's most prominent voices in wellness, medicine and academia delivered a pointed message to business operators on Tuesday: the country's next competitive leap will not come from better massage techniques or more attractive resorts, but from the ability to prove — in hard clinical numbers — that time spent in Thailand measurably extends a customer's life.

 

Speaking at a national seminar entitled "Beyond Relaxation: Innovation, Science and the Future of Value Creation in the Wellness Industry", hosted by the National Innovation Agency (NIA), the Ministry of Higher Education, Science, Research and Innovation (MHESI), and Chulalongkorn University, Krod Rohanasatien, consultant to the chairman and CEO of Chiva-Som International Health Resort, opened with a sweeping reframing of Thailand's economic identity.

 

The country, he argued, is at an inflection point in its development arc — having moved from an agricultural economy to an industrial one, and then into mass tourism — and is now positioned to make a fourth transition into what he called a Wellness Economy. 

 

The global forces driving that shift are not abstract: burnout, digital isolation, the loneliness epidemic, and the rapid ageing of populations across Asia are pushing consumers away from temporary indulgence and towards sustained, meaningful health restoration. 
 

"Wellness is no longer seen as luxury," he said. "It has become mainstream."

 

 

 

 

 

 

Thailand's starting position, he noted, is stronger than most people appreciate. The country's wellness economy stood at approximately US$42.7 billion in 2024 — yet that represents barely 0.63 per cent of the global market, a share he likened to "taking a single teaspoon from an enormous gold mine." 

 

The opportunity, he said, lies not in building new services from scratch but in recognising and scientifically validating what Thailand already possesses: its agricultural abundance, its tradition of holistic Thai medicine, its sensory culture, and above all, its irreplaceable DNA of human service. 

 

"Thailand will not just be a place to rest," he said. "It will become the world's new sanctuary."

 

 

The most detailed and commercially specific address came from Dr Tanupol Virunhagarun, chief executive of BDMS Wellness Clinic and BDMS Wellness Resort, who arrived armed with data on ageing biology, population trends and the financial logic of preventive medicine.

 

 

 

Dr Tanupol opened with an unusual disclosure: the entire BDMS Wellness Group — now operating 25 branches nationwide and drawing patients from 150 countries — was seeded with an initial investment of nearly 50,000 million baht from BDMS Group, committed on the personal conviction of the late founder Dr Prasert Prasarttong-Osoth that Thailand's healthcare system needed to pivot from treating the sick to preventing illness in the first place. 

 

"He told me: do whatever it takes to keep people from getting sick," Dr Tanupol recalled. "I asked him — if I succeed, won't your hospitals lose revenue? He laughed and said he had more money than he could spend."
 

 

 

 

 

The doctor's central argument rested on a concept he urged every operator in the room to commit to memory: the gap between health span — the years lived in good health — and lifespan.

 

The global average lifespan is 73; Thailand's is 77. But health span globally is only 63 and in Thailand 67. That ten-year gap, he said, represents a decade of suffering, medical costs and economic drain — and it is widening, not narrowing, as modern medicine becomes better at keeping people alive but not necessarily well. 

 

"We have been fooled by rising life expectancy figures," he said. "Doctors are just better at keeping people alive while ill. That is not what we want."

 

 

 

 

 

The financial case for wellness investment, he argued, is now irrefutable.

 

Drawing on World Health Organisation modelling, he told the audience that every baht invested in preventive health returns 35 baht in economic benefit — rising to 46 baht when the investment is made at the policy level. 

 

Thailand currently spends more than 600 billion baht annually on healthcare, almost entirely on treating illness after the fact. Even modest diversion of that budget towards prevention, he said, would be transformative.

 

Dr Tanupol was equally direct about the science underpinning commercial wellness services. He pointed to research on telomere length — the chromosomal marker of biological ageing — showing that obesity shortens life by nine years, insufficient exercise by another nine, chronic stress by ten, and air pollution equivalent to passive smoking by seven. 

 

 

 

 

 

Together, those four factors account for the full 35-year gap between theoretical lifespan and current reality. 

 

"Mindfulness meditation is the only intervention ever proven to slow telomere shortening with statistical significance," he said. "No drug in the world can do what consistent meditation does — and Thailand has been teaching this for centuries."

 

The commercial opportunity he identified was specific. Wellness tourists visiting Thailand already spend an average of 100,000 baht per trip — and unlike conventional tourists, they cause minimal environmental damage, do not smoke, are rarely disruptive, and tend to return.

 

Thailand ranked third globally last year in wellness tourism growth, at 36.4 per cent, trailing only the UAE and India. He expects that gap to close. 

 

 

 

He was, however, candid about the limits of private enterprise alone. His BDMS Wellness Group has expanded aggressively—acquiring hotel partnerships with Laguna Phuket, Sri Panwa and properties in Samui; building organic farms at Sukhothai Airport; opening an award-winning restaurant; and planning a landmark Wellness City development near Lumphini Park—yet the single largest constraint on further growth, he said, is not capital but qualified personnel. 

 

"Wellness doctors are very hard to find. My problem is not a shortage of patients — it is a shortage of doctors," he said. "That is why I need everyone in this room."
 

 

 

 

 

That opening was seized by Prof Dr Wilert Puriwat, president of Chulalongkorn University, who positioned the institution as the scientific backbone the industry requires. 

 

He described Thailand's wellness sector as having arrived at a genuine "turning point": it is internationally recognised for its hospitality and relaxation offerings but unable to access the far more lucrative medical and longevity wellness market without moving from "feeling" to measurable clinical outcome.

 

High-net-worth clients, he said, no longer accept subjective testimonials. 

 

They demand what he termed "Wellness ROI" — a quantifiable, scientifically verified return on their health investment.

 

 

 

 

Chulalongkorn, he said, is prepared to serve as that verification engine, offering a pathway he described as "From Bench to Bedside to Business": translating laboratory research into clinical trials, and clinical trials into commercially scalable products.

 

The university will offer fast-track scientific validation to industry partners, converting the phrase "I feel better" into auditable clinical outcomes.

 

"We will create a High-Touch meets High-Tech phenomenon," he said, "fusing Thai wisdom with world-class science in a concrete and demonstrable way."
 

 

Prof Wilert stressed that sustaining Thailand's position in global wellness over the long term requires three things working simultaneously: differentiation through research that proves Thailand offers something no other country can replicate; identity-building through data-driven branding that creates measurable consumer loyalty; and the cultivation of customers who become genuine advocates for the broader Thai wellness proposition. 

 

"We must build a brand with data," he said. "That turns customers into a voice that promotes Thailand's Wellness Economy for us."
 

 

 

 

 

 

Taken together, the three addresses sketched a division of roles that, if coordinated, could accelerate Thailand's advance from a 0.63 per cent share of a US$6.32 trillion global market to a position of genuine international leadership. 

 

Private operators such as BDMS and Chiva-Som provide the platform, the capital and the global patient base. Academic institutions such as Chulalongkorn provide the clinical validation and the research pipeline.

 

And the government – as both MHESI minister Dr Yodchanan Wongsawat and NIA executive director Dr Krithpaka Boonfueng argued in the morning session – provides funding mechanisms, regulatory sandboxes and the policy architecture to scale what works.

 

The only missing piece, as all five speakers converged in agreeing, is scientific evidence. Without it, Thailand's wellness sector remains permanently capped at what it can charge, perpetually vulnerable to competitors who will eventually acquire the technology while remaining unable to replicate the hospitality. With it, the ceiling disappears entirely.